Erespal (fenspiride)

27.08.2015 Updated 22.10.2019 8501 views

By MoH of Ukraine order No. 527 of 19.08.15, the package leaflet (hereinafter – the leaflet) for the original (reference) medicinal product containing fenspiride, namely ERESPAL®, syrup, was approved with amendments and additions to the leaflet sections: "Interaction with other medicinal products and other forms of interaction", "Special warnings and precautions for use", "Adverse reactions", "Children", "Use during pregnancy or breastfeeding", "Effects on ability to drive and use machines", "Contraindications".

Other materials in this section